Your account is not claimed yet. You can sign up with ORCID to claim your account.

Tigist Y Tamir

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2020
Publications (10 Years): 3

Top Topics

Toll Like Receptor

Lymph Node Metastasis

Inflammatory Response

Top Venues

The Journal of pathology

Scientific reports

Journal of cell science

Massachusetts Institute of Technology David H Koch Institute for Integrative Cancer Research

College of William and Mary Biology Department (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Massachusetts Institute of Technology David H Koch Institute for Integrative Cancer Research Jan 10o 2020

United States

Postdoctoral Associate :: Biological Engineering

Education History

College of William and Mary Biology Department

United States

BSC :: Biology

Publications

Tigist Y Tamir, David Harold Drewry, Carrow I Wells, Michael B Major, Alison D Axtman
PKIS deep dive yields a chemical starting point for dark kinases and a cell active BRSK2 inhibitor. Scientific reports 10 (1) (2020)
Brittany M Bowman, Stephanie A Montgomery, Travis P Schrank, Jeremy M Simon, Travis S Ptacek, Tigist Y Tamir, Kathleen M Mulvaney, Seth J Weir, Tuong T Nguyen, Ryan M Murphy, Liza Makowski, David Neil Hayes, Xiaoxin Luke Chen, Scott H Randell, Bernard E Weissman, Michael B Major
A conditional mouse expressing an activating mutation in NRF2 displays hyperplasia of the upper gastrointestinal tract and decreased white adipose tissue. The Journal of pathology 252 (2) (2020)
Tigist Y Tamir, Brittany M Bowman, Megan J Agajanian, Dennis Goldfarb, Travis P Schrank, Trent Stohrer, Andrew E Hale, Priscila F Siesser, Seth J Weir, Ryan M Murphy, Kyle M LaPak, Bernard E Weissman, Nathaniel J Moorman, Michael B Major
Gain-of-function genetic screen of the kinome reveals BRSK2 as an inhibitor of the NRF2 transcription factor. Journal of cell science 133 (14) (2020)